Ultragenyx Pharmaceutical (RARE) Prepaid Assets (2013 - 2026)

Ultragenyx Pharmaceutical (RARE) has 14 years of Prepaid Assets data on file, last reported at $68.0 million in Q1 2026.

• Quarterly Prepaid Assets rose 13.63% year-over-year to $68.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.0 million (up 13.63% YoY) and the FY2025 annual result came in at $61.0 million, up 52.5% from the prior year.
• Prepaid Assets improved to $68.0 million in Q1 2026 per RARE's latest filing, from $61.0 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $77.5 million in Q2 2022 and bottomed at $40.0 million in Q4 2024.
• The 5-year median for Prepaid Assets is $59.8 million (2025), against an average of $57.6 million.
• The widest annual swing landed in 2023, when Prepaid Assets slumped 35.15%; it then jumped 52.5% in 2025.
• Tracing RARE's Prepaid Assets over 5 years: stood at $68.9 million in 2022, then tumbled by 30.92% to $47.6 million in 2023, then declined by 15.99% to $40.0 million in 2024, then soared by 52.5% to $61.0 million in 2025, then climbed by 11.48% to $68.0 million in 2026.
• Per Business Quant, the three latest RARE Prepaid Assets figures stand at $68.0 million (Q1 2026), $61.0 million (Q4 2025), and $53.2 million (Q3 2025).

Peer Comparison